tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

AUPH Stock Latest News

Aurinia Pharmaceuticals Engages Investors at Key Conferences
Company AnnouncementsAurinia Pharmaceuticals Engages Investors at Key Conferences
3d ago
AUPH
Aurinia Pharmaceuticals AGM Shareholder Decisions
PremiumCompany Announcements
Aurinia Pharmaceuticals AGM Shareholder Decisions
21d ago
AUPH
Aurinia’s LUPKYNIS Shows Promise for Lupus Nephritis
PremiumCompany Announcements
Aurinia’s LUPKYNIS Shows Promise for Lupus Nephritis
30d ago
AUPH
Aurinia announces presentation on LUPKYNIS at EULAR 2024
PremiumThe Fly
Aurinia announces presentation on LUPKYNIS at EULAR 2024
30d ago
AUPH
Aurinia Pharmaceuticals issues letter to shareholders regarding Lucien Selce
PremiumThe Fly
Aurinia Pharmaceuticals issues letter to shareholders regarding Lucien Selce
1M ago
AUPH
Aurinia Pharmaceuticals Adjusts Equity Plan Shares
PremiumCompany AnnouncementsAurinia Pharmaceuticals Adjusts Equity Plan Shares
1M ago
AUPH
Aurinia Pharma to Present at 2024 Healthcare Conference
PremiumCompany Announcements
Aurinia Pharma to Present at 2024 Healthcare Conference
1M ago
AUPH
Aurinia’s LUPKYNIS Deemed Cost-Effective for Lupus
PremiumCompany Announcements
Aurinia’s LUPKYNIS Deemed Cost-Effective for Lupus
2M ago
AUPH
Aurinia Highlights LUPKYNIS Success in Lupus Treatment
PremiumCompany Announcements
Aurinia Highlights LUPKYNIS Success in Lupus Treatment
2M ago
AUPH
Aurinia Pharmaceuticals presents safety, efficacy data on LUPKYNIS
PremiumThe Fly
Aurinia Pharmaceuticals presents safety, efficacy data on LUPKYNIS
2M ago
AUPH
Aurinia Pharmaceuticals to Engage at RBC Healthcare Conference
PremiumCompany Announcements
Aurinia Pharmaceuticals to Engage at RBC Healthcare Conference
2M ago
AUPH
Aurinia Pharmaceuticals Sees Robust Growth in 2024
PremiumCompany Announcements
Aurinia Pharmaceuticals Sees Robust Growth in 2024
2M ago
AUPH
Aurinia Pharmaceuticals Files SEC Report
PremiumCompany AnnouncementsAurinia Pharmaceuticals Files SEC Report
2M ago
AUPH
Aurinia Pharmaceuticals still sees FY24 revenue $200M-$220M, consensus $224.25M
PremiumThe Fly
Aurinia Pharmaceuticals still sees FY24 revenue $200M-$220M, consensus $224.25M
2M ago
AUPH
Aurinia Pharmaceuticals reports Q1 EPS (7c), consensus (14c)
PremiumThe Fly
Aurinia Pharmaceuticals reports Q1 EPS (7c), consensus (14c)
2M ago
AUPH
Aurinia Advances Lupus Nephritis Education and Advocacy
PremiumCompany Announcements
Aurinia Advances Lupus Nephritis Education and Advocacy
2M ago
AUPH
Aurinia Pharmaceuticals Boosts Lupus Nephritis Awareness
PremiumCompany Announcements
Aurinia Pharmaceuticals Boosts Lupus Nephritis Awareness
2M ago
AUPH
Biotech Sector: M&A Fuels Renewed Excitement
PremiumMarket News
Biotech Sector: M&A Fuels Renewed Excitement
2M ago
NVS
XBI
Aurinia’s LUPKYNIS Wins FDA Label Update
PremiumCompany Announcements
Aurinia’s LUPKYNIS Wins FDA Label Update
2M ago
AUPH
Aurinia Pharmaceuticals: FDA approves updated LUPKYNIS label
PremiumThe FlyAurinia Pharmaceuticals: FDA approves updated LUPKYNIS label
2M ago
AUPH
Aurinia Pharmaceuticals to Present at Investor Conference
PremiumCompany Announcements
Aurinia Pharmaceuticals to Present at Investor Conference
3M ago
AUPH
Aurinia Pharmaceuticals Announces Q1 Results Date
PremiumCompany Announcements
Aurinia Pharmaceuticals Announces Q1 Results Date
3M ago
AUPH

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >